Clinical Trials Browser

Withdrawn × Pancreatic Neoplasms × tremelimumab × Clear all

NCT02868632 2019-04-05

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms